Pediatric bipolar disorder: Evidence-based psychopharmacological treatments

Journal of Child and Adolescent Psychiatric Nursing

Volumn 20, Issue 1, 2007, Pages 40-58

  Hamrin, Vanya ^a,b   Pachler, Maryellen ^c  

^a YALE UNIVERSITY SCHOOL OF NURSING   (United States)

^b West Haven Mental Health Clinic   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Pediatric bipolar disorder; Psychopharmacological management

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; TRANQUILIZER;

BEHAVIOR GENETICS; BIPOLAR DISORDER; CHILD; CHILD PSYCHIATRY; CLASSIFICATION; COMORBIDITY; DRUG COMBINATION; DRUG INTERACTION; DRUG MONITORING; EVIDENCE BASED MEDICINE; HUMAN; NEUROANATOMY; NEUROBIOLOGY; NURSING ASSESSMENT; PATIENT SELECTION; PHARMACOGENETICS; PSYCHIATRIC NURSING; PSYCHOPHARMACOLOGY; REVIEW; TREATMENT OUTCOME;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CHILD; CHILD PSYCHIATRY; COMORBIDITY; DRUG INTERACTIONS; DRUG MONITORING; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; GENETICS, BEHAVIORAL; HUMANS; NEUROANATOMY; NEUROBIOLOGY; NURSING ASSESSMENT; PATIENT SELECTION; PHARMACOGENETICS; PSYCHIATRIC NURSING; PSYCHOPHARMACOLOGY; TREATMENT OUTCOME;

EID: 34147130172     PISSN: 10736077     EISSN: 17446171     Source Type: Journal    
DOI: 10.1111/j.1744-6171.2007.00083.x     Document Type: Article

References (106)

1. Achenbach, T. (1991a). Manual for the Child Behavior Checklist/4-18 and 1991 profile. Burlington, VT: University of Vermont.
2. Achenbach, T. (1991b). Manual of the Teacher Report Form and the 1991 profile. Burlington, VT: University of Vermont.
3. Achenbach, T. M. (1991c). Manual for the Youth Self-Report Form and the 1991 profile. Burlington, VT: University of Vermont.
4. American Psychiatric Association. (2000). Dignostic and statistical manual of mental disorders (4th ed., Text Rev.). Washington, DC: American Psychiatric Association.
5. Barzman, D., DelBello, M., Kowatch, R., Warner, J., Rofey, D., Stanfod, K., et al. (2005). Adjunctive topiramate in hospitalized children and adolescents with bipolar disorder. Journal of Child and Adolscent Psychopharmacology, 15 (6), 931-937.
6. Biederman, J., Farone, S., Mick, E., Wozniak, J., Chen, L., Ouellette, C., et al. (1996). Attention-deficit hyperactivity disorder and juvenile mania: An overlooked comorbidity? Journal of Child and Adolescent Psychiatry, 35 (8), 997-1008.
7. Biederman, J., Farone, S., Wozniak, J., Mick, E., Kwon, A., & Aleardi, M. (2004). Further evidence of unique developmental phenotypic correlates of pediatric bipolar disorder: Findings from a large sample of clinically referred preadolescent children assessed over the last 7 years. Journal of Affective Disorders, 82, S45-58.
8. Beiderman, J., Mick, E., Hammerness, P., Harpld, T., Aleardi, M., Doughtery, M., et al. (2005). Open label 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder for preschool-age children. Biological Psychiatry, 58 (7), 589-594.
9. Birmaher, B., Axelson, D., Strober, M., Gill, M., Valeri, S., Chiappetta, L., et al. (2006). Clinical course of children and adolescents with bipolar spectrum disorders. Archives of General Psychiatry, 63, 175-183.
10. Birmaher, B., Kennah, A., Brent, D., Ehmann, M., Bridge, J., & Axelson, D. (2002). Is bipolar disorder specifically associated with panic disorder in youths? Journal of Clinical Psychiatry, 63, 414-419.
11. Blumberg, H., Fredricks, C., Wang, F. Kalmar, J., Spencer, L., Papademetris, X., et al. (2005). Preliminary evidence for persistent abnormalities in amygdale volumes in adolescents and young adults with bipolar disorder. Bipolar Disorders, 7, 570-576.
12. Bowden, C., Calabrese, J., Ketter, T., Sachs, G., White, R., & Thompson, T. (2006). Impact of lamotrigine and lithium on weight in obese and non-obese patients with bipolar I disorder. American Journal of Psychiatry, 163 (7), 1199-1201.
13. Bschor, T., Lweitza, U., Sasse, J., Adli, M., Koberle, U., & Bauer, M. (2003). Lithium augmentation in treatment resistant depression. Clinical evidence, serotonergic and endocrine mechanisms. Pharmacopsychiatry, 36 (3), S230-234.
14. Calabrese, J., Shelton, M., Rapport, D., Youngstrom, E., Jackson, D., Jackson, K., et al. (2005). A 20 month, double blind, maintenance study of lithium vs. divalproex monotherapy in bipolar I and II disorder accompanied by rapid cycling. American Journal of Psychiatry, 162, 2152-2161.
15. Carandang, C., Maxwell, D., Robbins, D., & Oesterheld, J. (2003). Lamotrigine in adolescent mood disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 42 (7), 750-751.
16. Chang, A., Li, P., & Warsh, J. (2003). Altered cAMP-dependent protein kinase subunit immunolabeling in post-mortem brain from patients with bipolar affective disorder. Journal of Neurochemistry, 84 (4), 781-791.
17. Chang, K., Karchemsky, A., Barnea-Goraly, N., Garrett, A., Simeonova, D., & Reiss, A. (2005). Reduced amygdalar grey matter volume in familial pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 44 (6), 565-573.
18. Chang, K., Steiner, H., & Ketter, T. (2000). Psychiatric phenomenology of child and adolescent bipolar offspring. Journal of the American Academy of Child and Adolescent Psychiatry, 39 (4), 453-60.
19. Carlson, G., & Kelly, K. (1998). Manic symptoms in psychiatrically hospitalized children-what do they mean? Journal of Affective Disorders, 51, 123-135.
20. Dalton, E., Cate-Carter, T., Mundo, E., Parikh, S., & Kennedy, J. (2003). Suicide risk in bipolar patients: The role of co-morbid substance use disorders. Bipolar Disorders, 5 (1), 58-61.
21. Davanzo, P., Gunderson, B., Belin, T., Mintz, J., Pataki, C., Ott, D., et al. (2003). Mood stabilizers in hospitalized children with bipolar disorder: A retrospective chart review. Psychiatry and Clinical Neurosciences, 57 (5), 504-513.
22. Dean, B. (2004). The neurobiology of bipolar disorder: Findings using human postmortem central nervous system tissue. Australian and New Zealand Journal of Psychiatry, 38 (3), 135-140.
23. DelBello, M., Kowatch, R., Caleb, A., Stanford, K., Welge, J., Barzman, D., et al. (2006). A double-blind randomized pilot study comparing quetiapine and divalproex sodium for adolescent mania. Journal of the American Academy of Child and Adolescent Psychiatry, 45 (3), 305-313.
24. Delbello, M., Findling, R., Kushner, S., Wang, D., Olson, W., Capece, J., et al. (2005). A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 44 (6), 539-547.
25. Delbello, M., Kowatch, R., Warner, J., Schwiers, M., Rappaport, K., Daniels, J., et al. (2002). Adjunctive topiramate treatment for pediatric bipolar disorder: A retrospective chart review. Journal of Child and Adolescent Psychopharmacolgy, 12 (4), 323-330.
26. Delbello, M., Schwiers, M., Rosenberg, H., & Strakowski, S. (2002). A double-blind, randomized, placebo-controlled study of quetiapine, as adjunctive treatment for adolescent mania. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1216-1223.
27. Dickstein, D., Milham, M., Nugent, A., Drevets, W., Charney, D., Pine, D., et al. (2005). Frontotemporal alterations in pediatric bipolar disorder. Results of a voxel-based morphometry study. Archives of General Psychiatry, 62 (7), 734-741.
28. DuVal, S. (2005). Six-year-old Thomas diagnosed with pediatric onset bipolar disorder: A case study. Journal of Child and Adolescent Psychiatric Nursing, 18, 38-42.
29. Emamghoreishi, M., Li, P., Schlichter, L., Parikh, S., Cooke, R., & Warsh, J. (2000). Associated disturbances in calcium homeostasis and G protein-mediated cAMP signaling in bipolar I disorder. Biological Psychiatry, 48 (7), 665-673.
30. Friedman, E., & Wang, H. (1996). Receptor-mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects. Journal of Neurochemistry, 67 (3), 1145-1152.
31. Findling, R., Calabrese, J., & Youngstrom, E. (2003). Divalproex sodium vs. placebo in the treatment of youth at genetic high risk for developing bipolar disorder. Bipolar Disorder, 5, 47.
32. Findling, R., Gracious, B., McNamara, N., Youngstrom, E., Demeter, M., Branicky, L., et al. (2001). Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder. Bipolar Disorder, 3(4), 2002-2010.
33. Findling, R., McManera, N., Stansbrey, R., Gracious, B., Whipkey, R., Demeter, M., et al. (2006). Combination lithium and divalproex sodium in pediatric bipolar symptom restabilization. Journal of the American Academy of Child and Adolescent Psychiatry, 45(2), 142-148.
34. Findling, R., McNamara, N., Stansbrey, R., Gracious, E., Whipkey, R., Demeter, C., et al. (2005). Combination lithium and divalproex sodium in pediatric bipolarity. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 895-901.
35. Findling, R., McNamara, N., Youngstrom, E., Stansbrey, R., Gracious, B., Reed, M., et al. (2005). A double blind 18 month trial of lithium versus diavalproex maintenance treatment in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 44(5), 409-417.
36. Frazier, J., Biederman, J., Tohen, M., Feldman, P., Jacobs, T., Toma, V., et al. (2001). A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 11, 239-250.
37. Frazier, J., Chiu, S., Breeze, J., Makris, N., Lange, N., Kennedy, D., et al. (2005). Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. American Journal of Psychiatry, 162, 1256-1265.
38. Frazier, J., Meyer, M., Biederman, J., Wozniak, J., Wilens, T., Spencer, T., et al. (1999). Risperidone treatment for juvenile bipolar disorder: A retrospective chart review. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 960-965.
39. Geller, B., Cooper, T., Sun, K., Zimerman, B., Razier, J., Williams, M., et al. (1998). Double blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependence. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 171-178.
40. Geller, B., Craney, J., Bolhofner, K., Delbello, M., Williams, M., & Zimerman, B. (2001). One-year recovery and relapse rates of children with prepubertal and early adolescent bipolar disorder phenotype. American Journal of Psychiatry, 158, 303-305.
41. Geller, B., Craney, J., Bolhofner, K., Nickelsburg, M., Williams, M., & Zimerman, B. (2002). Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar phenotype. American Journal of Psychiatry, 159, 927-933.
42. Geller, B., Tillman, R., Craney, J., & Bolhofner, K. (2004). Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Archives of General Psychiatry, 61(5), 459-467.
43. Geller, B., Williams, M., Zimerman, B., Frazier, J., Beringer, L., & Warner, K. (1998). Prepubertal and early adolescent bipolarity differentiate from ADHD by manic symptoms, grandiose delusions, ultra-rapid or ultradian cycling. Journal of Affective Disorders, 51, 81-91.
44. Geller, B., Zimerman, B., William, M., Bolhofner, K., Craney, J., DelBello, M., et al. (2001). Reliablity of the Washington University in St. Louis Kiddie Schedule of Affective Disorders and Schizophrenia (Wash-U-KSADS) Mania and rapid cycling sections. Journal of the American Academy of Child and Adolescent Psychiatry, 40(4), 450-455.
45. Goldstein, T., Birmaher, D., Axelson, D., Ryan, N. D., Strober, M., Gill, M., et al. (2005). History of suicide attempts in pediatric bipolar disorder: Factors associated with increased risk. Bipolar Disorders, 7(6), 525-535.
46. Gracious, B., Youngstrom, E., Findling, R., & Calabrese, J. (2002). Discriminative validity of the parent version of the Young Mania Rating Scale. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1350-1359.
47. Hamrin, V., & Bailey, K. (2001). Use of gabapentin in a preadolescent boy with ADHD and bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 11(3), 301-308.
48. Hamrin, V., & Scahill, L. (2005). Selective serotonin reuptake inhibitors in children and adolescents with major depression: Current controversies and recommendations. Issues in Mental Health Nursing, 26(4), 433-450.
49. Joffe, H., Cohen, L., Suppes, T., McLauglin, W., Lavori, P., Adams, J., et al. (2006). Valproate in associated with new-onset oligoamenorrhea with hyperandrogneism in women with bipolar disorder. Biological Psychiatry, 59, 1078-1086.
50. Kafantaris, V., Coletti, D., Dicker, R., Padula, G., & Kane, J. (2003). Lithium treatment of acute mania in adolescents: A large open trial. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1038-1045.
51. Kapczinski, F., Frey, B., & Zannatto, Z. (2004). Physiopathology of bipolar disorders: What has changed in the last 10 years? Brazilian Psychiatric Review, 26(S3), 17-21. Kashani, H., Beck, N., Hoeper, E., Fallahi, C., Corcoran, C., McAllister, J., et al. (1987). Psychiatric disorders in a community sample of adolescents. American Journal of Psychiatry, 144(8), 584-589.
52. Kashani, H., Beck, N., Hoeper, E., Fallahi, C., Corcoran, C., McAllister, J., et al. (1987). Psychiatric disorders in a community sample of adolescents. American Journal of Psychiatry, 144(8), 584-589.
53. Kaufman, J., Birmaher, B., Brent, D., Rao, U., Flynn, C., Moreci, P., et al. (1997). Schedule of Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (KSADSPL): Initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 980-988.
54. Kaur, S., Sassi, R., Axelson, D., Nicoletti, M., Brambilla, P., Monkul, E., et al. (2005). Cingulate cortex anatomical abnormalities in children and adolescents with bipolar disorder. American Journal of Psychiatry, 162, 1643-1643.
55. Kogan, J., Otto, M., Bauer, M., Dennehy, E., Miklowitz, D., Zhang, H., et al. (2004). Demographic and diagnostic characteristics of the first 1000 patients enrolled in the systematic treatment enhancement program for bipolar disorder. (STEP-BD). Bipolar Disorders, 6(6), 460-469.
56. Kovacs, M., & Pollock, M. (1995). Bipolar disorder and comorbid conduct disorder in childhood and adolescence. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 715-723.
57. Kowatch, R., & Debello, M. (2005). Pharmacotherapy of children and adolescents with bipolar disorder. Psychiatric Clinics of North America, 28, 385-397.
58. Kowatch, R., & Debello, M. (2006). Pediatric bipolar disorder: Emerging diagnostic and treatment approaches. Child and Adolescent Psychiatric Clinics of North America, 15, 73-108.
59. Kowatch, R., Suppes, T., Carmody, T., Bucci, J., Hume, J., Kromelis, M., et al. (2000). Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 713-720.
60. Kowatch, R., Suppes, T., & Gilfillan, S. K. (1995). Clozapine treatment of children and adolescent with bipolar disorder and schizophrenia: A clinical case series. Journal of Child and Adolescent Psychopharmacology, 5(4), 241-253.
61. Leibenluft, E., Charney, D., Towbin, K., Banqoo, R., & Pine, D. (2003). Defining clinical phenotypes of juvenile mania. American Journal of Psychiatry, 160(3), 430-437.
62. Leverich, G., Altshuler, L., Suppes, T., McElroy, S., Kupka, R., Denicoff, K., et al. (2006). Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. American Journal of Psychiatry, 163, 232-239.
63. Lewinsohn, P., Klein, D., & Seeley, J. (1995). Bipolar disorders in a community sample of older adolescents: Prevalence, phenomenology, comorbidity, and course. Journal of the American Academy of Child and Adolescent Psychiatry, 34(4), 454-463.
64. Lewinsohn, P., Klein, D., & Seeley, J. (2000). Bipolar disorder during adolescence and young adulthood in a community sample. Bipolar Disorder, 2, 281-293.
65. Manji, H., & Lenox, K. (1999). Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: Molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biological Psychiatry, 46(10), 1328-1351.
66. Masi, G., Mucci, M., & Millepiedi, S. (2002). Clozapine in adolescent inpatients with acute mania. Journal of Child and Adolescent Psychopharmacology, 12(2), 93-99.
67. MacMillan, C., Korndorfer, S., Rao, S., Fleisher, C., Mezzacappa, E., & Gonzalez-Heydrich, J. (2006). A comparison of divalproex and oxcarbazepine in aggressive youth with bipolar disorder. Journal of Psychiatric Practice, 12(4), 214-222.
68. Marchand, W. (2004). Quetiapine adjunctive and monotherapy for pediatric bipolar disorder: A retrospective chart review. Journal of Child and Adolescent Psychopharmacology, 14(3), 405-411.
69. McClellen, J. (2005). Commentary: Treatment guidelines for child and adolescent bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 44(3), 236-239.
70. McClure, E., Treland, J., Snow, J., Schmajuk, M., Dickstein, D., Towbin, K., et al. (2005). Deficits in social and cognition and response flexibility in pediatric bipolar disorder. American Journal of Psychiatry, 162, 1644-1651.
71. Mohr, W. (2001). Bipolar disorder in children. Journal of Psychosocial Nursing, 39(3), 12-23.
72. Neuman, R., Geller, B., Rice, J., & Todd, R. (1997). Increased prevalence and earlier onset of mood disorders among relatives of prepubertal versus adult probands. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 466-473.
73. Nierenberg, A., Ostacher, M., Calabrese, J., Ketter, R., Marangell, T., Miklowitz, D., et al. (2006). Treatment resistant bipolar depression: A step-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol or riperidone. American Journal of Psychiatry, 163(2), 210-216.
74. Pavuluri, M., Schenkel, L., Subhash, A., Harral, E., Hill, K., Herbener, E., et al. (2006). Neurocognitive function in unmedicated manic and medicated euthymic pediatric bipolar patients. American Journal of Psychiatry, 163, 28-293.
75. Pavuluri, M., Birmaher, B., & Naylor, M. (2005). Pediatric bipolar disorder: A review of the past 10 years. Journal of the American Academy of Child and adolescent Psychiatry, 44(9), 846-871.
76. Pavuluri, M., Henry, D., Carbray, J., Naylor, M., & Janicak, P. (2005). Divalproex sodium for pediatric mixed mania: A 6-month prospective trial. Bipolar Disorders, 7, 266-273.
77. Pavuluri, M., Henry, D., Devineni, B., Carbray, J., Naylor, M., & Janicak, P. (2004). A pharmacotherapy algorithm for stabilization and maintenance of pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 43(7), 859-867.
78. Pavuluri, M., Henry, D., Carbray, J., Sampson, G., Naylor, M., & Janicak, P. G. (2004). Open-label prospective trial of ripseridone in combination with lithium or divalproex sodium in pediatric mania. Journal of Affective Disorders, 82, S103-S111.
79. Payne, J., Quiroz, J., Gould, T., Zarate, C., & Manji, H. (2004). The cellular neurobiology of bipolar disorder. In D. Charney, & E. Nestler (Eds.), Neurobiology of mental illness (2nd ed.). New York: Oxford University Press.
80. Pies, W. (1998). Handbook of essential psychopharmacology. Washington, DC: American Psychiatric Press.
81. Potash, J., & DePaulo, J. (2000). Searching high and low: A review of the genetics of bipolar disorder. Bipolar Disorder, 2, 8-26.
82. Rich, B., Vinton, D., Roberson-Nay, R., Hommer, R., Berghorst, L., Mcclure, E., et al. (2006). Limbic hyperactivation during processing of neutral facial expressions in children with bipolar disorder. Proceedings of the National Academy of Sciences of the United States of America, 103(23), 8900-8905.
83. Scahill, L., Farkas, L., & Hamrin, V. (2001). Lithium in children and adolescents. Journal of Child and Adolescent Psychiatric Nursing, 14(2), 89-93.
84. Scheffer, R., Kowatch, R., Carmody, T., & Rush, A. (2005). Randomized, placebo controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. American Journal of Psychiatry, 162, 58-64.
85. Schreier, H. (1998). Risperidone for young children with mood disorders and aggressive behavior. Journal of Child and Adolescent Psychopharmacology, 8(1), 49-59.
86. Singh, V., Muzina, D., & Calabrese, J. (2005). Anticonvulsants in bipolar disorder. Psychiatric Clinics of North America, 28, 301-324.
87. Soutullo, C., Sorter, M., Foster, K., McElroy, S., & Keck, P. (1999). Olanzapine in the treatment of adolescent acute mania: A report of seven cases. Journal of Affective Disorders, 53, 279-83.
88. Spleiss, O., van Calker, D., Scharer, L., Adamovic, K., Berger, M., & Gebicke-Haerter, P. (1998). Abnormal G protein alpha(s)-and alpha(i2)-subunit mRNA expression in bipolar affective disorder. Molecular Psychiatry, 3(6), 512-520.
89. Strober, M., DeAntonio, M., Schmidy-Lackner, S., Freeman, R., Lampert, C., & Diamond, J. (1998). Early childhood attention deficit hyperactivity disorder predicts poorer response to acute lithium therapy in adolescent mania. Journal of Affective Disorders, 51, 148-151.
90. Suppes, T., Leverich, F., Keck, P., Nolen, W., Denicoff, K., Altshuler, L., et al. (2001). The Stanley Foundation Bipolar Treatment Outcome Network II: Demographics and illness characteristics of the first 261 patients. Journal of Affective Disorders, 67, 45-59.
91. Tillman, R., Geller, B., Bolhofner, K., Craney, J., Williams, J., & Zimerman, B. (2003). Ages of onset and rates of syndromal and sybsyndromal comorbid DSM-IV diagnoses in a prepubertal and early adolescent bipolar disorder phenotype. Journal of the American Academy of Child and Adolescent Psychiatry, 42(12), 1486-1493.
92. Wagner, K., Kowatch, R., Emslie, G., Findling, R., Wilens, T., McCague, K., et al. (2006). A double-blind, randomized, placebocontrolled trial of oxcabazepine in the treatment of bipolar disorder in children and adolescents. American Journal of Psychiatry, 163, 1179-1186.
93. Wagner, K., Weller, E., Carlson, G., Sachs, G., Biederman, J., Frazier, J., et al. (2002). An open-label trial of divalproex in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1224-1230.
94. West, S., Strakowski, S., Sax, K., McElroy, S., Keck, P., & Mcdonvile, B. (1996). Phenomenology and comorbidity of adolescents hospitalized for the treatment of acute mania. Biological Psychiatry, 39, 458-460.
95. White, S. (2003). Mechanism of action of newer anticonvulsants. Journal of Clinical Psychiatry, 64(8), 5-8.
96. Wozniak, J., Biederman, J., & Richards, J. (2001). Diagnostic and therapeutic dilemmas in the management of pediatric-onset bipolar disorder. Journal of Clinical Psychiatry, 62(14), 10-15.
97. Wozniak, J., Biederman, J., Faraone, S., Frazier, J., Kim, J., Millstein, R., et al. (1997). Mania in children with pervasive developmental disorder revisited. Journal of the American Academy of Child and Adolescent Psychiatry, 36(11), 1552-1559.
98. Wozniak, J., Beiderman, J., Kiely, K., Ablon, J., Faraone, S., Mundy, E., et al. (1995). Manic-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 867-876.
99. Wozniak, J., Crawford, M., Biederman, J., Faraone, S., Spencer, T., Taylor, A., et al. (1999). Antecedents and complications of trauma in boys with ADHD: Findings from a longitudinal study. Journal of the American Academy of Child and Adolescent Psychiatry, 38(1), 48-55.
100. Wozniak, J., Monuteaux, M., Richards, J., Lail, K., Faraone, S., & Biederman, J. (2003). Convergence between structured diagnostic interviews and clinical assessment on the diagnosis of pediatric onset mania. Biological Psychiatry, 53, 938-944.
101. Young, R., Biggs, J., Ziegler, V., & Meyer, D. (1978). A rating scale for mania: Reliability, validity, and sensitivity. British Journal of Psychiatry, 133, 429-435.
102. Youngstrom, E., Danielson, R., Findling, R., Gracious, B., & Calabrese, J. (2002). Factor structure of the Young Mania Rating Scale for use with youths age 5-17 years. Journal of Clinical Child and Adolescent Psychology, 31, 567-572.
103. Youngstrom, E., & Duax, J. (2005). Evidence-based assessment of pediatric bipolar disorder, Part I: Base rate and family history. Journal of the American Academy of Child and Adolescent Psychiatry, 44(7), 712-717.
104. Youngstrom, E., Findling, R., Calabrese, J., Gracious, B., Demeter, C., Bedoya, D., et al. (2004). Comparing the diagnostic accuracy of six potential screening instruments for bipolar disorder in youth ages 5-17 years. Journal of the American Academy of Child and Adolescent Psychiatry, 43(7), 847-858.
105. Youngstrom, E., Findling, R., Danielson, R., & Calabrese, J. (2001). Discriminative validity of parent report of hypomanic and depressive symptoms on the General Behavior Inventory. Psychological Assessment, 13(2), 267-276.
106. Youngstrom, E., Gracious, B., Danielson, C., Findling, R., & Calabrese, J. (2003). Toward an integration of parent and clinician report on the Young Mania Rating Scale. Journal of Affective Disorders, 77, 179-190.